Intravenous aspirin at reperfusion does not reduce infarct size in the dog with a residual critical stenosis

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 4, 1999, Pages 575-583

  Libersan, Danielle ^a,b   Quan, Eric ^a,b   Merhi, Yahye ^a,b   Uzan, André ^c   Laperrière, Luc ^d   Latour, Jean Gilles ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c SANOFI   (France)

^d Rhône Poulenc Rorer   (Canada)

Author keywords

Aspirin; Myocardial infarction; Neutrophils; Platelets; Reperfusion; Stenosis

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLSALICYLIC ACID; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE REPERFUSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; THROMBOCYTE; THROMBOCYTE AGGREGATION; TISSUE LEVEL; TREATMENT OUTCOME;

6-KETOPROSTAGLANDIN F1 ALPHA; ANESTHESIA; ANIMALS; ASPIRIN; BLOOD CELL COUNT; CELL MOVEMENT; CORONARY DISEASE; DOGS; FEMALE; INFARCTION; INFUSIONS, INTRAVENOUS; MALE; MALONDIALDEHYDE; NEUTROPHILS; PLATELET AGGREGATION; REPERFUSION INJURY;

EID: 0032857979     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199910000-00015     Document Type: Article

References (49)

1. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wave-front phenomenon of ischemic cell death: I. myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977;56: 786-94.
2. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest 1985;76:1713-9.
3. Jolly SR, Kane WJ, Bailie MB, Abrams GD, Lucchesi BR. Canine myocardial reperfusion injury: its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 1984; 54:277-85.
4. Wildenthal K. Lysosomal alterations in ischemic myocardium: result or cause of myocellular damage? J Mol Cell Cardiol 1978;10: 595-603.
5. McCluskey ER, Murphree S, Saffitz JE, Morrison AR, Needleman P. Temporal changes in 12-HETE formation in two models of canine myocardial infarction. Prostaglandins 1985;29:387-403.
6. Gavin JB, Humphrey SM, Herdson PB. The no-reflow phenomenon in ischemic myocardium. Int Rev Exp Pathol 1983;25:361-83.
7. Engler RL, Schmid-Schönbein GW, Pavelec RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983;111:98-111.
8. Rousseau G, Hébert D, Libersan D, Khalil A, St-Jean G, Latour J-G. Importance of platelets in myocardial injury after reperfusion in the presence of residual coronary stenosis in dogs. Am Heart J 1993;125:1553-63.
9. Van Lierde J, De Geest H, Verstraete M, Van de Werf F. Angiographic assessment of the infarct-related residual coronary stenosis after spontaneous or therapeutic thrombolysis. J Am Coll Cardiol 1990;16:1545-9.
10. Barrabés JA, Garcia-Dorado D, Oliveras J, et al. Intimal injury in a transiently occluded coronary artery increases myocardial necrosis: effect of aspirin. Eur J Physiol 1996;432:663-70.
11. Mullane KM, Fornabaio D. Thromboxane synthetase inhibitors reduce infarct size by a platelet-dependent, aspirin-sensitive mechanism. Circ Res 1988;62:668-78.
12. 2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve. J Pharmacol Exp ner 1989;248:484-91.
13. Raymenants E, Yang B, Nicolini F, Behrens P, Lawson D, Mehta JL. Verapamil and aspirin modulate platelet-mediated vasomotion in arterial segments with intact and disrupted endothelium. J Am Coll Cardiol 1993;22:684-9.
14. Hasçelik G, Sener B, Hasçelik Z. Effect of some anti-inflammatory drugs on human neutrophil chemotaxis. J Int Med Res 1994;22: 100-6.
15. Dembinska-Kiec A, Zmuda A, Wenhrynowicz O, Stachura J, Peskar BA, Gryglewski RJ. Selectin-P-mediated adherence of platelets to neutrophils is regulated by prostanoids and nitric oxide. Int J Tissue React 1993;15:55-64.
16. Merhi Y, Provost P, Guidoin R, Latour J-G. Importance of platelets in neutrophil adhesion and vasoconstriction following arterial injury by angioplasty in pigs. Arterioscler Thromb Vasc Biol 1997; 17:1185-91.
17. Haynes DR, Wright PFA, Gadd SJ, Whitehouse MW, Vernon-Roberts B. Is aspirin a prodrug for antioxidant and cytokine-modulating oxymetabolites? Agents Actions 1993;39:49-58.
18. Díaz-González F, González-Alvaro I, Campanero MR, et al. Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs. J Clin Invest 1995;95:1756-65.
19. 2 and adenylate cyclase. Immunology 1995;84:638-44.
20. Rousseau G, Provost P, Tran D, Caillé G, Latour J-G. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog. J Pharmacol Exp Ther 1994; 268:1252-60.
21. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95: 351-8.
22. Diodati J, Théroux P, Latour J-G, Lacoste L, Lam JYT, Waters D. Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction. Am J Cardiol 1990;66:683-8.
23. Yu SK, Latour J-G. Potentiation by α and inhibition by β-adrenergic stimulations of rat platelet aggregation: a comparative study with human and rabbit platelets. Thromb Haemost 1977;3:413-22.
24. Roux S, Christeller S, Lüdin E. Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a metaanalysis. J Am Coll Cardiol 1992;19:671-7.
25. Jolly SR, Schumacher WA, Kunkel SL, Abrams GD, Lidicoat J, Lucchesi BR. Platelet depletion in experimental myocardial infarction. Basic Res Cardiol 1985;80:269-79.
26. Mullane KM, McGiff JC. Platelet depletion and infarct size in an occlusion-reperfusion model of myocardial ischemia in anesthetized dogs. J Cardiovasc Pharmacol 1985;7:733-8.
27. Barstad RM, Ørvim U, Hamers MJAG, Tjønfjord GE, Brosstad FR, Sakariassen KS. Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood flow. Thromb Haemost 1996;75:827-32.
28. McEver RP, Moore KL, Cummings RD. Leukocyte trafficking mediated by selectin-carbohydrate interactions. J Biol Chem 1995; 270:11025-8.
29. Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit adenosine diphosphate-induced platelet α-granule release. Blood 1993;82:505-12.
30. X -containing carbohydrate reduces infarct size: role of selectins in myocardial reperfusion injury. Am J Physiol 1996;271:H2086-96.
31. X analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion. Circulation 1994; 90:2390-401.
32. Weyrich AS, Ma XL, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion. J Clin Invest 1993;91: 2620-9.
33. Bazzoni G, Dejana E, Del Maschio A. Platelet-neutrophil interactions: possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica 1991;76:491-9.
34. 2 responses in stimulated human neutrophils. Lab Invest 1988;58:37-47.
35. Maugeri N, Evangelista V, Piccardoni P, et al. Transcellular metabolism of arachidonic acid: increased platelet thromboxane generation in the presence of activated polymorphonuclear leukocytes. Blood 1992;80:447-51.
36. Tsuji T, Nagata K, Koike J, Todoroki N, Irimura T. Induction of superoxide anion production from monocytes and neutrophils by activated platelets through the P-selectin-sialyl Lewis X interaction. J Leukoc Biol 1994;56:583-7.
37. 4: impact of aspirin therapy. Circulation 1992;86:56-63.
38. Jolly SR, Lucchesi BR. Effect of BW755C in an occlusion-reperfusion model of ischemic myocardial injury. Am Heart J 1983;106:8-13.
39. Folts JD, Crowell Jr EB, Rowe GG. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 1976;54:365-70.
40. Maalej N, Folts JD. Increased shear stress overcomes the anti-thrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries. Circulation 1996;93:1201-5.
41. Gallagher KP, Folts JD, Rowe GG. Comparison of coronary arteriograms with direct measurements of stenosed coronary arteries in dogs. Am Heart J 1978;95:338-47.
42. Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost 1993;70:119-23.
43. Simpson PJ, Mitsos SE, Ventura A, et al. Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation. Am Heart J 1987;113:129-37.
44. Hohlfeld T, Strobach H, Schrör K. Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury. J Pharmacol Exp Ther 1993;264:397-405.
45. van Jaarsveld H, Kuyl JM, van Zyl GF, Barnard HC. Salicylate in the perfusate during ischemia/reperfusion prevented mitochondrial injury. Res Commun Mol Pathol Pharmacol 1994;86:287-95.
46. Armstead WM, Mirro R, Busija DW, Leffler CW. Postischemic generation of superoxide anion by newborn pig brain. Am J Physiol 1988;255:H401-3.
47. Ikeda H, Koga Y, Oda T, et al. Free oxygen radicals contribute to platelet aggregation and cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. J Am Coll Cardiol 1994;24:1749-56.
48. de Lorgeril M, Basmadjian A, Lavallée M, et al. Influence of leukopenia on collateral flow, reperfusion flow, reflow ventricular fibrillation and infarct size in dogs. Am Heart J 1989;117:523-32.
49. Kilgore KS, Lucchesi BR. Reperfusion injury after myocardial infarction: the role of free radicals and the inflammatory response. Clin Biochem 1993;26:359-70.